Parkside Investments LLC bought a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Rating) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 900 shares of the medical equipment provider’s stock, valued at approximately $239,000.
A number of other hedge funds have also made changes to their positions in ISRG. BlackRock Inc. grew its position in shares of Intuitive Surgical by 5.6% in the third quarter. BlackRock Inc. now owns 27,887,777 shares of the medical equipment provider’s stock valued at $5,227,284,000 after purchasing an additional 1,477,885 shares in the last quarter. Price T Rowe Associates Inc. MD grew its position in shares of Intuitive Surgical by 3.3% in the second quarter. Price T Rowe Associates Inc. MD now owns 25,692,735 shares of the medical equipment provider’s stock valued at $5,156,788,000 after purchasing an additional 816,066 shares in the last quarter. Goldman Sachs Group Inc. grew its position in shares of Intuitive Surgical by 49.0% in the second quarter. Goldman Sachs Group Inc. now owns 1,888,228 shares of the medical equipment provider’s stock valued at $378,987,000 after purchasing an additional 621,063 shares in the last quarter. Grantham Mayo Van Otterloo & Co. LLC purchased a new stake in shares of Intuitive Surgical in the second quarter valued at approximately $121,152,000. Finally, Mackenzie Financial Corp grew its position in shares of Intuitive Surgical by 244.5% in the third quarter. Mackenzie Financial Corp now owns 730,312 shares of the medical equipment provider’s stock valued at $136,890,000 after purchasing an additional 518,321 shares in the last quarter. Institutional investors and hedge funds own 81.96% of the company’s stock.
Analyst Ratings Changes
A number of equities research analysts have recently issued reports on ISRG shares. Deutsche Bank Aktiengesellschaft upped their price target on Intuitive Surgical from $230.00 to $245.00 in a research report on Wednesday, January 25th. Citigroup lowered their price objective on Intuitive Surgical from $318.00 to $305.00 and set a “buy” rating for the company in a research report on Wednesday, January 25th. StockNews.com initiated coverage on Intuitive Surgical in a research report on Thursday. They issued a “hold” rating for the company. Argus increased their price objective on Intuitive Surgical from $265.00 to $320.00 and gave the stock a “buy” rating in a research report on Thursday, December 22nd. Finally, BTIG Research lowered their price objective on Intuitive Surgical from $316.00 to $279.00 and set a “buy” rating for the company in a research report on Wednesday, January 25th. Six equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $273.83.
Insider Buying and Selling at Intuitive Surgical
Intuitive Surgical Trading Down 1.1 %
Shares of NASDAQ ISRG opened at $237.80 on Friday. The stock has a market cap of $83.29 billion, a P/E ratio of 64.97, a PEG ratio of 4.79 and a beta of 1.29. Intuitive Surgical, Inc. has a 12-month low of $180.07 and a 12-month high of $308.97. The business’s fifty day simple moving average is $244.17 and its 200-day simple moving average is $238.37.
Intuitive Surgical (NASDAQ:ISRG – Get Rating) last announced its quarterly earnings data on Tuesday, January 24th. The medical equipment provider reported $1.23 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.25 by ($0.02). Intuitive Surgical had a net margin of 21.25% and a return on equity of 11.27%. The company had revenue of $1.66 billion during the quarter, compared to analyst estimates of $1.66 billion. During the same quarter in the previous year, the business posted $1.30 earnings per share. The firm’s revenue was up 6.7% on a year-over-year basis. On average, equities analysts forecast that Intuitive Surgical, Inc. will post 4.21 EPS for the current fiscal year.
About Intuitive Surgical
Intuitive Surgical, Inc engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G.
- Get a free copy of the StockNews.com research report on Intuitive Surgical (ISRG)
- MarketBeat Week in Review – 3/13 – 3/17
- This Small Tech With Big Growth Prospects Is Nearing A Buy Point
- Don’t Chase FedEx Higher, Wait For The Pullback
- 3 Stocks For A Defensive Tech Portfolio
- Milk the Dividends on These 3 Cash Cows
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Rating).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.